Abeona Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Abeona Therapeutics generated cash of -$37,009,000, which is more than the previous year. Cash used in financing activities reached the amount of $37,057,000 last year. Net change in cash is therefore $256,000.
Cash Flow
| 2014 | -1.61M | 0 | 12.70M |
|---|---|---|---|
| 2015 | -10.42M | 3.38M | 35.65M |
| 2016 | -13.01M | -519K | 42.53M |
| 2017 | -22.93M | -860K | 92.40M |
| 2018 | -39.11M | -85.08M | 5.47M |
| 2019 | -62.82M | 59.97M | 113.90M |
| 2020 | -35.01M | -83.71M | 1.93M |
| 2021 | -65.66M | 66.06M | 24.86M |
| 2022 | -43.48M | -23.96M | 43.17M |
| 2023 | -37.00M | 208K | 37.05M |
ABEO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.55M | 38.82M | 13.57M | 130.36M | 19.31M | 138.03M | 69.14M | 40.13M | 11.52M | 424K |
Operating activities | ||||||||||
Net income | -54.18M | -39.69M | -84.93M | -84.23M | -76.28M | -56.67M | -27.31M | -21.87M | -14.52M | -26.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.19M | 4.57M | 4.46M | 5.60M | 8.67M | 2.36M | 741K | 825K | 551K | 11K |
Stock-based compensation expense | 4.76M | 3.05M | 8.91M | 8.18M | 8.23M | 0 | 5.91M | 4.82M | 4.36M | 1.30M |
| Deferred income tax benefit | 4.76M | 3.05M | 8.91M | 8.18M | 8.23M | 0 | 5.91M | 4.82M | 4.36M | 1.30M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 3M | -3M | 0 | 81K | 26K | 17K | -9K | -79K | 39K |
Inventories | 0 | 0 | -16.08M | 0 | -81K | -1.02M | -2.58M | 156K | -316K | 669K |
Accounts payable | 2.04M | -10.49M | 825K | -2.17M | -1.70M | 7.66M | -1.30M | 2.81M | -1.17M | 33K |
Cash generated by operating activities | -37.00M | -43.48M | -65.66M | -35.01M | -62.82M | -39.11M | -22.93M | -13.01M | -10.42M | -1.61M |
Investing activities | ||||||||||
Purchases Of Investments | -51.63M | -78.21M | -20.16M | -170.47M | 0 | -136.09M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -331K | -130K | -4.15M | -1.33M | -6.50M | -19.49M | -860K | -519K | -308K | 0 |
Acquisitions Net | 0 | 1.73M | 4.15M | 1.33M | 0 | 19.49M | 0 | 0 | 3.69M | 0 |
Cash generated by investing activities | 208K | -23.96M | 66.06M | -83.71M | 59.97M | -85.08M | -860K | -519K | 3.38M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 37.38M | 46.96M | 25.48M | 1K | 112.93M | 5.47M | 86.17M | 42.18M | 31.41M | 12.30M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.75M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 37.05M | 43.17M | 24.86M | 1.93M | 113.90M | 5.47M | 92.40M | 42.53M | 35.65M | 12.70M |
Net Change In Cash | 256K | -24.27M | 25.25M | -116.79M | 111.05M | -118.72M | 68.60M | 29.00M | 28.61M | 11.09M |
Cash at end of period | 14.81M | 14.55M | 38.82M | 13.57M | 130.36M | 19.31M | 137.75M | 69.14M | 40.13M | 11.52M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |